ARTICLE | Financial News
Kadmon raises $100M ahead of new trials
June 12, 2018 8:20 PM UTC
Kadmon Holdings Inc. (NYSE:KDMN) added $0.35 (10%) to $3.68 on Tuesday after it raised $100 million in two offerings through the sale of 30.3 million shares at $3.30. The company sold the shares in a follow-on underwritten by Jefferies and H.C. Wainwright, and in a registered direct offering to institutional investors.
The price is a 1% discount to Kadmon's close of $3.35 on Monday, before it proposed the offering after market hours...
BCIQ Company Profiles
BCIQ Target Profiles
Rho-associated coiled-coil containing protein kinase 2 (ROCK2)